Limb-Girdle Muscular Dystrophy Panel

  • Test Code:
    1297
  • Department:
  • Test Synonyms:
    Neuromuscular disorders ANO5 CAPN3 CAV3 COL6A1 COL6A2 COL6A3 DAG1 DES DMD DYSF EMD FHL1 FKRP FKTN FLNC GAA GNE ISPD LMNA MYOT PLEC POMGNT1 POMT1 POMT2 SGCA SGCB SGCD SGCG SYNE1 SYNE2 TCAP TRIM32 TTN VCP
View Test

Long QT Syndrome and Short QT Syndrome

  • Test Code:
    2300
  • Department:
  • Test Synonyms:
    Syncopal Episodes Torsades de pointes tachyarrythmia Atrial Fibrillation AKAP9 ANK2 CACNA1C CALM1 CASQ2 CAV3 KCNE1 KCNE2 KCNH2 KCNJ2 KCNQ1 RYR2 SCN4B SCN5A SNTA1
View Test

Low HDL Panel

  • Test Code:
    1860
  • Department:
  • Test Synonyms:
    Tangier disease ABCA1 ABCG1 APOA1 LCAT SCARB1
View Test

Lung Cancer Panel (EGFR, ALK, ROS1)

  • Test Code:
    4825
  • Department:
  • Test Synonyms:
    EGFR Gene Mutation (Exons 18, 19, 20 & 21) FISH for ALK and ROS1 Gene Rearrangements
View Test

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More